BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The 4ᵗʰ Wet AMD and Diabetic Eye Disease Drug Development Summ
 it is returning to Boston this March to unite 70+ industry-based retinal 
 vascular experts from the likes of Bayer\, Boehringer Ingelheim\, Genente
 ch\, Novartis and OcuTerra\, at the only industry-dedicated forum to tran
 sform the potential of treatment of chronic\, sight-threatening retinal v
 ascular diseases to improve patient outcomes.\n\nHear fresh perspectives 
 from the new companies speaking at the 2024 meeting including Aviceda The
 rapeutics\, Bayer\, Boehringer Ingelheim\, OcuTerra\, Novartis\, Genentec
 h\, and Adverum Biotechnologies and discover robust new content focusing 
 on industry-specific topics such as new targets\, in vivo and in vitro mo
 dels\, retinal imaging and clinical biomarkers and new modalities for ret
 inal and choroidal neovascularization.\n\nDate and Time: On Tue\, 19 Mar 
 2024 08:00 - Thu\, 21 Mar 2024 15:00\n
DTEND:20240321T150000
DTSTAMP:20260512T223117Z
DTSTART:20240319T080000
LOCATION:Wyndham Boston Beacon Hill\, Wyndham Boston Beacon Hill\, 5 Bloss
 om Street\, Boston\, Massachusetts\, 02114\,
SEQUENCE:0
SUMMARY:The 4ᵗʰ Wet AMD and Diabetic Eye Disease Drug Development Summit i
 s returning to Boston this March to unite 70+ industry-based retinal vasc
 ular exp...
UID:bddc6030-af36-4aed-95b5-b1a2eb705ae9
END:VEVENT
END:VCALENDAR